Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your intestines release after eating. Clinical trials show patients using semaglutide lose an average of 15-22% of their body weight over 68 weeks. This injectable medication works by slowing stomach emptying, increasing fullness signals to your brain, and improving how your body handles blood sugar.

How Semaglutide Works for Weight Loss

Semaglutide activates GLP-1 receptors throughout your digestive system and brain, creating three powerful effects on appetite control. First, it slows the rate at which food moves from your stomach to your small intestine, keeping you satisfied longer after meals. Second, it sends stronger satiety signals directly to your brain's appetite centers, reducing cravings and portion sizes naturally.

The medication also improves your metabolic response to food by helping your pancreas release insulin more efficiently. This dual action on appetite suppression and metabolic function explains why semaglutide produces weight loss that persists even when patients reduce calorie intake without hunger or constant willpower struggles. Most patients notice appetite reduction within the first week, with steady weight loss beginning in weeks two through four of treatment.

Common Side Effects and How to Manage Them

Nausea is the most frequently reported side effect, affecting roughly 25-40% of patients in early treatment weeks. This typically improves as your body adjusts, usually within 2-4 weeks, but eating smaller meals spaced throughout the day and staying hydrated can reduce nausea intensity. Ginger tea, eating protein-rich foods first, and avoiding greasy or overly sweet foods also help many patients tolerate the medication more comfortably during adjustment periods.

Constipation occurs in about 20-30% of patients because semaglutide slows gastrointestinal movement while reducing overall food intake. Increasing water consumption to at least 3 liters daily, adding fiber-rich foods like leafy greens and whole grains, and gentle movement like walking can significantly ease this side effect. Some patients benefit from a stool softener during the first month, and these effects usually diminish as your dose stabilizes and your digestive system adapts.

Vomiting, diarrhea, and abdominal discomfort occur less frequently but resolve more quickly when managed with smaller portions and simple foods. Fatigue during the first 1-2 weeks is temporary and typically reflects your body's adjustment to reduced calorie intake rather than a medication problem. If side effects persist beyond 4-6 weeks or become severe, your PlexusDx healthcare provider can adjust your dosing strategy or recommend additional support.

Semaglutide Dosing and Treatment Timeline

PlexusDx delivers compounded semaglutide injections starting at $149 per month, with your dose adjusted based on your individual response and health goals rather than arbitrary schedules. Treatment typically begins at a lower dose to allow your body to adjust, then increases gradually over 4-8 weeks until you reach your optimal effective dose. Your dose may need to go up as your treatment progresses, but your price won't—PlexusDx maintains flat monthly pricing across all dose levels.

Most patients inject once weekly on the same day each week for convenience and consistency. The injection itself is painless, using a thin needle similar to insulin pens, and takes only seconds to administer. Your PlexusDx provider tracks your weight loss progress, symptom management, and metabolic markers during regular check-ins to ensure you're progressing safely and effectively toward your goals.

Personalized Treatment with Genetic Insights

Your genetic makeup influences how powerfully you respond to GLP-1 therapy and whether additional compounds might enhance your results. PlexusDx offers the Precision Peptide Genetic Test for $99 after your first month of treatment, analyzing 14 metabolic pathways and 150+ genetic insights including key variants in GLP1R, GIPR, FTO, and MC4R genes. These results help your provider determine whether semaglutide alone is optimal for you or whether adding a second compound like tirzepatide could improve outcomes.

Patients with certain genetic profiles may experience faster initial weight loss or require dose adjustments sooner than others, and genetic testing helps predict these patterns before they occur. Understanding your peptide-pathway genetics removes guesswork from treatment personalization and increases the likelihood of finding your ideal medication and dose quickly. This precision approach means fewer wasted months on suboptimal regimens and faster achievement of your weight loss and health goals.

Why Patients Choose PlexusDx for Compounded Semaglutide

PlexusDx compounds semaglutide through licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and purity without the premium brand-name pricing. All formulations are shipped directly to your home across all 50 states, with no insurance required and no membership fees—just straightforward, accessible weight loss medication. Your semaglutide injections are HSA and FSA eligible, allowing you to use pre-tax healthcare savings to lower your out-of-pocket costs.

Beyond medication access, PlexusDx provides ongoing clinical support, regular progress monitoring, and the option to add genetic testing for truly personalized optimization. Your treatment journey includes regular check-ins with healthcare providers familiar with GLP-1 therapy, appetite management strategies, and nutrition counseling to maximize your results. Whether you're starting your weight loss journey or optimizing an existing treatment plan, PlexusDx combines affordability, convenience, and personalized clinical care in one integrated platform.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results from semaglutide?

Most patients notice reduced appetite within 1 week and begin steady weight loss by weeks 2-4 as their dose increases. Clinical data shows average weight loss of 15-22% over 68 weeks, though individual results vary based on adherence, diet, exercise, and genetics. PlexusDx tracks your progress monthly to ensure you're moving toward your goals.

Is semaglutide safe for long-term use?

Clinical trials spanning up to 2 years show semaglutide is generally safe when monitored by a healthcare provider, with side effects typically improving after initial adjustment weeks. Patients with a personal or family history of thyroid cancer or multiple endocrine neoplasia should discuss risks with their PlexusDx provider before starting treatment. Regular monitoring ensures any concerns are caught early and managed appropriately.

Can I afford semaglutide with PlexusDx pricing?

PlexusDx compounded semaglutide injections start at just $149 per month with flat pricing across all dose levels—your dose may go up, but your price won't. All formulations are HSA and FSA eligible, and coverage is available in all 50 states without requiring insurance or membership fees. Most patients find compounded semaglutide significantly more affordable than brand-name alternatives.

What makes compounded semaglutide from PlexusDx different from brand-name versions?

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which manufacture pharmaceutical-grade medication at a fraction of brand-name costs while maintaining identical quality and purity. You receive the same active ingredient in the same delivery method, just without corporate marketing overhead. Compounded versions offer flexibility in dosing and scheduling that brand-name medications sometimes lack.

How does the Precision Peptide Genetic Test help my semaglutide treatment?

PlexusDx's $99 genetic test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes, revealing whether you're a strong responder to semaglutide alone or whether adding a second compound might improve results. Testing your peptide-pathway genetics after your first month lets your provider optimize your treatment based on your biology rather than trial-and-error, accelerating your progress toward lasting weight loss.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves